Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0609-06

Test kit used in the assessment of breast cancer patients for whom Herceptin therapy is being considered...

Biogenex Laboratories, Inc. / initiated 2006-02-09 / Terminated

Biogenex Laboratories began a recall of Test kit used in the assessment of breast cancer patients for whom Herceptin therapy is being considered. BioGenex brand InSite HER-2/neu Monoclonal Antibody... on . The reason FDA records is "Products produce granular staining in immunostained tissue sections, which may lead to misdiagnosis due to false positive result". As of , the recall status on record is Terminated.

Recall record

Recall number
Z-0609-06
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Biogenex Laboratories, Inc.
Product
Test kit used in the assessment of breast cancer patients for whom Herceptin therapy is being considered. BioGenex brand InSite HER-2/neu Monoclonal Antibody, Automated; Model number: AM134-10MP; Lot Numbers: AM134P1005
Product code
MVC System, Test, Her-2/Neu, Ihc
Reason for recall
Products produce granular staining in immunostained tissue sections, which may lead to misdiagnosis due to false positive result.
FDA root cause
Other
Action
On 2/9/06, the firm issued letters via UPS to all of its consignees, informing them of the affected products and providing instructions on the recall.
Quantity in commerce
1 unit
Distribution
Nationwide. Italy, and United Kingdom. The product was released for distribution to 21 consignees nationwide to CA, FL, GA, IA, IL, NC, NJ, NY, TX, VT, WA, and WI. One VA account: VA Medical Center, Gwen Levy, Bld. 500, Room 1238, 11301 Wilshire Blvd., Los Angeles, CA 90073. 2 overseas consignees distributed the product to Italy (Space Imports Export SPL, Via Ranzato, 12, 1-20128 Milano, Italy and United Kingdom (Launch Diagnosis, West Yoke Farm unit 11, Michaels, Lane, Sevenoaks, Kent, TN15 7EP United Kingdom
Product codes and lots
Lot Numbers: AM134P1005